Filing Details

Accession Number:
0000950170-23-060499
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-07 18:19:54
Reporting Period:
2023-11-06
Accepted Time:
2023-11-07 18:19:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501796 Aura Biosciences Inc. AURA Biological Products, (No Disgnostic Substances) (2836) 320271970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1889633 Elisabet Pinos Los De C/O Aura Biosciences, Inc.
80 Guest Street
Boston MA 01235
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-06 3,800 $2.74 184,740 No 4 M Direct
Common Stock Disposition 2023-11-06 7,449 $12.03 177,291 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-11-06 3,800 $0.00 3,800 $2.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
361,163 2028-02-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 131,412 Indirect By EdIP Revocable Trust
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.
  4. This option is fully vested.